NCT01779401: Clopidogrel Response Evaluation and AnTi-Platelet InterVEntion in High Thrombotic Risk PCI Patients |
|
|
| Completed | N/A | 1078 | RoW | Clopidogrel 75mg, Clopidogrel 150mg, Aspirin 100mg, Cilostazol 100mg | Chinese Academy of Medical Sciences, Fuwai Hospital, Beijing Municipal Health Bureau, Haemonetics Corporation, Zhejiang Otsuka Pharmaceutical Co., Ltd. | Coronary Heart Disease | 09/16 | 09/16 | | |
